Owner: PMO Lead
Class: Operational Record (Class 3)
Status: Active
Last Updated: 2026-06-21
Cycle: 2026-06-21__release-v5.1

---

## Phase 3

**Phase:** Sprint Execution
**Cycle:** 2026-06-21__release-v5.1
**Section anchor:** `## Phase 3`
**Filed:** 2026-06-21
**Reviewed by:** PMO Lead
**Prior cycle Phase 3 checked:** claude/cycles/2026-06-03__release-v5.0/lessons_learnt_cycle.md — found; v5.0 Phase 3 items reviewed.

**Prior cycle deferred items check:**
- v5.0 Phase 3 deferred: "Frontend observable AC Playwright coverage velocity — consider dedicated sprint story for BLG-FE-61 rather than deferred backlog item" (target v5.1, owner PMO Lead).
  - **RESOLVED:** ST-04 in v5.1 was explicitly the BLG-FE-61 Playwright coverage story. Third-consecutive-recurrence pattern closed — delivered in same cycle as the deferral target.
- v5.0 Phase 4 deferred: "Update delivery_verification_prompt.md §-1.3 Tier 2 for agent-mediated signer format acceptance" (target v5.1, owner Head of Specs Team).
  - **RESOLVED:** ST-03 in v5.1 delivered the patch. `delivery_verification_prompt.md` v2.9→v3.0. Tier 2 advisory closed.

**prompt_change_log.md deferred patch check:**
All v5.0 deferred patches resolved in v5.1 without skip. No patches carried ≥2 cycles without a `prompt_change_log.md` entry.

| friction_item | phase | type | classification | action | owner | target_date |
|---------------|-------|------|----------------|--------|-------|-------------|
| Both v5.0 deferred items (BLG-FE-61 Playwright coverage and delivery_verification_prompt.md §-1.3 Tier 2 signer format) resolved in v5.1 as planned. Explicit BLG ID + target cycle at deferral time confirmed as the reliable mechanism for cross-cycle closure. | Phase 3 | E | action-now | Positive resolution. Both deferred items closed on schedule. No process change needed — deferral tracking pattern is working. | Sprint Execution Engine | — |
| DEV-v51-EPIC01-01 (P3): Known Deviations section for the `pass_rate` computation deviation was documented in `qa_evidence_EPIC-01.md` at execution time but was NOT added to the canonical spec (`si05-telegram-message-format-spec.md`) during the ST-01 commit, contrary to LL-v3.4-P3-04 advisory (file in canonical spec in the same commit). Root cause: deviation was identified during post-commit QA review rather than at the implementation commit point — the advisory is harder to apply retrospectively. Corrected in sprint close commit. | Phase 3 | A | action-now | Known Deviations section added to `si05-telegram-message-format-spec.md` in sprint close commit. Advisory to watch: when qa_evidence log records a new deviation reference (DEV-*), verify the corresponding canonical spec entry exists before sprint close. Recommend adding to pre-close mental checklist (no prompt change required). | PMO Lead | — |
| All 6 stories delivered as autonomous — zero delegation, zero escalations, zero items returned to backlog. Session-resume merge gate sync (LL-v3.9-P3-1) correctly detected all 3 EPICs merged between sessions and bypassed merge gate conditions to proceed directly to sprint close. | Phase 3 | E | action-now | Positive pattern. LL-v3.9-P3-1 session-resume detection working correctly. No process change needed. | Sprint Execution Engine | — |
| ST-01 AC-09 (Telegram staging delivery) and ST-05 AC-01 (compliance_summary live data) are staging-only ACs deferred per sprint planning designation. Both I&O Owner sign-offs outstanding. No process friction — staging-only designation made at planning, accepted at sprint sign-off. Correct outcome. | Phase 3 | E | action-now | Positive: staging-only AC designation pattern (LL-v3.1-EX-01) working as designed. Two staging ACs correctly scoped to a subsequent staged verification sprint. | Sprint Execution Engine | — |

**Recurrence Notes:**
- **BLG-FE-61 Playwright coverage (three-cycle recurrence pattern):** Resolved in v5.1. Closed. No further monitoring needed.
- **delivery_verification_prompt.md §-1.3 Tier 2 signer format (v5.0 Phase 4 deferred):** Resolved in v5.1 (ST-03). Closed.
- **Known Deviations section not filed in canonical spec at execution time:** First occurrence. Corrected at sprint close. Monitor for recurrence. If recurs in next cycle, add explicit verification step to QA evidence checklist.
- **Autonomous class sign-off (BLG-GOV-19) applied to EPIC-02:** Sixth consecutive correct application. Stable.

---

## Process improvements actioned this run

- ST-03: `delivery_verification_prompt.md` §-1.3 Tier 2 patched to accept agent-mediated signer format — v2.9→v3.0. Resolves v5.0 Phase 4 Tier 2 advisory recurrence risk.
- Known Deviations section added to `si05-telegram-message-format-spec.md` for DEV-v51-EPIC01-01 — corrects canonical spec filing gap from execution time (LL-v3.4-P3-04 advisory).

---

## New files created this run

- `claude/cycles/2026-06-21__release-v5.1/sprint_close.md`
- `claude/cycles/2026-06-21__release-v5.1/lessons_learnt_cycle.md` (this file)

---

## Outstanding deferred patches

None.
